Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в листопаді 2018 (uk)
- artículu científicu espublizáu en payares de 2018 (ast)
- scientific article published on 30 November 2018 (en)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Agnès Noël
- Silvia Blacher
- Erik Maquoi
- Sophie Château-Joubert
- Cassandre Yip
- Pierre Foidart
- Elodie Montaudon
- Joëlle Collignon
- Mehdi Lienard
- Véronique Jossa
- Jean Radermacher
- Laetitia Montero-Ruiz
- Michel Coibion
|
rdfs:label
| - Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy (en)
- Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy (nl)
|
skos:prefLabel
| - Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy (en)
- Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy (nl)
|
name
| - Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy (en)
- Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy (nl)
|
author
| |
author
| |
title
| |
title
| - Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1158/1078-0432.CCR-18-1880
|
is about
of | |
is cites work
of | |
is cites work
of | |